|
Press Releases |
|
 |
|
Wednesday, September 15, 2021 |
|
華領醫藥與國藥控股簽署供應鏈戰略合作協議 加速商業化佈局 |
2021年9月13日,華領醫藥技術(上海)有限公司(「華領醫藥」,香港聯交所股份代號:2552)與國藥控股股份有限公司(「國藥控股」,香港聯交所股份代號:1099)簽署供應鏈戰略合作協議,將在物流倉儲、供應鏈管理和渠道信息化等方面展開深入合作 more info >> |
|
Hua and Sinopharm Announced Supply Chain Strategic Cooperation |
On September 13, 2021, Hua Medicine (Shanghai) Ltd. (the "Hua Medicine", Stock Code: 2552.HK) has signed a supply chain strategic cooperation agreement with Sinopharm Group Co., Ltd. (the "Sinopharm", Stock Code: 1099). more info >> |
|
Thursday, August 19, 2021 |
|
华领医药公布2021年中期业绩 |
华领医药(「公司」,香港联交所股份代号:2552.HK),今天宣布公司及其附属公司截至2021年6月30日止,6个月(「报告期」)的综合业绩。 more info >> |
|
華領醫藥公佈2021年中期業績 |
華領醫藥(「公司」,香港聯交所股份代號:2552.HK),今天宣佈公司及其附屬公司截至2021年6月30日止,6個月(「報告期」)的綜合業績。 more info >> |
|
Hua Medicine Announces 2021 Interim Results |
Hua Medicine (the "Company", Stock Code: 2552.HK), today announces the consolidated results of the Company and its subsidiaries for the six months ended June 30, 2021 (the "Reporting Period"). more info >> |
|
Friday, April 23, 2021 |
|
华领医药糖尿病首创新药多扎格列艾汀NDA获NMPA受理!为全球首个葡萄糖激酶激活剂 |
华领医药(「公司」,香港联交所股份代号:2552.HK),今天宣布,糖尿病首创新药多扎格列艾汀( dorzagliatin)递交的NDA申请已获国家药品监督管理局(NMPA)新药审评中心(CDE)受理。多扎格列艾汀成为全球范围内首个提交新药上市申请的葡萄糖激酶激活剂类(GKA)糖尿病治疗药物,并有望成为在中国首先上市的全球首创新药(FIC)。 more info >> |
|
華領醫藥糖尿病首創新藥多扎格列艾汀NDA獲NMPA受理!為全球首個葡萄糖激酶激活劑 |
華領醫藥(「公司」,香港聯交所股份代號:2552.HK),今天宣布,糖尿病首創新藥多扎格列艾汀(dorzagliatin)遞交的NDA申請已獲國家藥品監督管理局(NMPA)新藥審評中心(CDE)受理。 more info >> |
|
Hua Medicine Announces Acceptance of a New Drug Application for Dorzagliatin in China - First Glucokinase Activator (GKA) Globally |
Hua Medicine (the "Company", Stock Code: 2552.HK), today announced that the New Drug Application (NDA) for dorzagliatin for the treatment of Type 2 Diabetes (T2D) was accepted by the China National Medical Products Administration (NMPA). more info >> |
|
Friday, March 19, 2021 |
|
Milestone Development Achieved in Clinical Trials and Commercialization, Hua Medicine's Dorzagliatin Readying for NDA Submission |
Hua Medicine (2552.HK), today announces the audited annual results of the Company and its subsidiaries for the year ended December 31, 2020 (the "Reporting Period"). more info >> |
|
华领医药公布2020年全年业绩 |
华领医药(「公司」,香港联交所股份代号:2552.HK),今天宣布公司及其附属公司截至2020年12月31日止经审核的全年业绩(「报告期」)。 more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
荧德控股年度收益增加32.8%创新高
May 17, 2022 23:02 HKT/SGT
|
|
|
熒德控股年度收益增加32.8%創新高
May 17, 2022 23:01 HKT/SGT
|
|
|
Vistar Holdings Hits Record High Annual Revenue Up by 32.8% Y-o-Y
May 17, 2022 23:00 HKT/SGT
|
|
|
莲鑫集团下属莲鑫基金与安谋科技中方股东就收购安谋科技51%股权签署意向书
May 17, 2022 21:30 HKT/SGT
|
|
|
神鋼集團:關於日本國內首次低碳高爐鋼材''Kobenable Steel''的商品化
May 17, 2022 16:00 HKT/SGT
|
|
|
神钢集团:关于日本国内首次低碳高炉钢材''Kobenable Steel''的商品化
May 17, 2022 16:00 HKT/SGT
|
|
|
Kobe Steel to launch "Kobenable Steel", Japan's first low CO2 blast furnace steel
May 17, 2022 16:00 HKT/SGT
|
|
|
Deputy Directors from Kenyan Ministry of ICT and ICT Authority along with INTERPOL's Director of Cybercrime to speak at CyFrica 2022
May 17, 2022 15:09 HKT/SGT
|
|
|
积极回馈投资者产品屡获殊荣 金嗓子用实力铸就坚强品牌内核
May 17, 2022 14:28 HKT/SGT
|
|
|
積極回饋投資者產品屢獲殊榮 金嗓子用實力鑄就堅強品牌內核
May 17, 2022 14:27 HKT/SGT
|
|
|
Yew Lee Pacific Group Berhad Launches Prospectus for ACE Market IPO
May 17, 2022 12:30 HKT/SGT
|
|
|
三菱重工、バーレーンの大手国営アルミニウム精錬会社・アルバ社とEPC契約を締結
May 17, 2022 12:20: JST
|
|
|
昭和電工、不飽和ポリエステル樹脂およびビニルエステル樹脂の販売価格改定を発表
May 17, 2022 11:30: JST
|
|
|
Alba Signs Agreement with Mitsubishi Power & SEPCOIII as EPC Contractor for Block 4 in Power Station 5
May 17, 2022 12:26 JST
|
|
|
富士通と理化学研究所、スーパーコンピュータ「富岳」とシミュレーション融合型AIを活用した次世代IT創薬技術の共同研究を開始
May 17, 2022 11:20: JST
|
|
|
|
More News >> |
|
|
|
|
|